Legal Opinion of Jiangsu Century Tongren Law Firm on the implementation of differentiated dividends in the 2023 profit distribution of Jiangsu Kangyuan Pharmaceutical Co., Ltd.

SZSI · May 25

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.